oncology
1,857 projects
breast cancer168leukemia137skin cancer106prostate cancer99colorectal cancer78lung cancer67pancreatic cancer42liver cancer37cervical cancer10bladder cancer10head and neck cancer7
HEDoctoral network2027–2031France
TTRAIL · Transferable Trustworthy Radiotherapy with Artificial Intelligence
24 partners · 9 countries
HEDoctoral network2027–2030France
cisCODE · Training a New Generation to Decode the Human Cis-Regulatory Genome
28 partners · 12 countries
HEDoctoral network2027–2030Spain
radio3D · Next-Generation Radiopharmaceuticals for Glioblastoma and Pancreatic Cancer: A 3D Perspective
21 partners · 9 countries
HEDoctoral network2027–2030Spain
DECODES · Deciphering the Splicing Code in Human Disease
16 partners · 9 countries
HEDoctoral network2027–2030Germany
FutureMIND · Training Europe’s Future Leaders in AI-driven Neuro-Oncology Diagnostics and Discovery
17 partners · 8 countries
HEDoctoral network2027–2030Austria
FlexCAT · Training program to engage flexible and disordered protein targets for therapeutic development: The oncogene β-catenin as showcase.
21 partners · 9 countries
HEIndividual fellowship2027–2029United Kingdom
PerFection · Peroxisome-Human Papillomavirus Infection Nexus and Implications
HEIndividual fellowship2027–2029France
IT-PREDICT · Predicting immunotherapy response in melanoma and non-small cell lung cancer patients using an extracellular vesicle-derived miRNA signature and a non-invasive CRISPR-based detection assay.
HEIndividual fellowship2027–2029Switzerland
scPheNOME · single-cell Phenomics for Navigating Oncogene-induced Morphological and Expression heterogeneity
HEIndividual fellowship2027–2029United Kingdom
ReadSSB · Reading DNA Single-Strand Breaks via Topology Physics in Solid-State Nanopores
HEIndividual fellowship2027–2028Italy
RESIST-CCA · Unravelling Malignant Cholangiocyte Subpopulations that Drive Chemoresistance in Cholangiocarcinoma
HEIndividual fellowship2027–2029Belgium
GUT-SCAN · GUT-commensal Strain for Cancer Assessment and Notification
HEIndividual fellowship2027–2030Italy
PHENOS · PHENOtyping targeted single-cell via integrated digital microfluidics and optoelectronic tweezerS
2 partners · 2 countries
HEIndividual fellowship2027–2029Belgium
EstroPatch · Continuous Estrogen Monitoring Patch
2 partners · 2 countries
HEStaff exchange2027–2030Greece
CTC4CLINIC · EXPLORING THE MECHANISM OF METASTASIS/DEVELOPMENT OF NEW TESTS TO ENROLL CIRCULATING TUMOR CELLS (CTCs) INTO CLINICAL PRACTICE
12 partners · 7 countries
HEIndividual fellowship2027–2029Austria
SelenoResist · Targeting selenocysteine metabolism as a novel vulnerability in refractory non-small-cell lung cancer
HEIndividual fellowship2027–2029Italy
DECAGE · Decoding Immune Aging in Chronic Hepatitis B
HEIndividual fellowship2027–2029Austria
Hi-HelicBots · Material–Structure Synergistic Design for High-Speed Magnetically Actuated Helical Microrobots
2 partners · 2 countries
HEIndividual fellowship2027–2029Denmark
NuSEN · Persistent rDNA damage in senescence: Linking nucleolar dysfunction to genome instability and inflammatory signaling
HEIndividual fellowship2027–2029Italy
EPIC-AML · Targeting EP300/CBP in AML: from mechanistic discovery to therapeutic innovation
HEIndividual fellowship2027–2029Germany
ION-CANDEL · Ion channelome of solid tumours: Novel immunotherapy targets for cancer-specific mRNA and drug delivery
HEIndividual fellowship2027–2029France
tRansGlio · Investigating the role of tRNA-dependent translational control in the onset and progression of Glioblastoma.
HEIndividual fellowship2027–2029Portugal
GLYCOANALYTICS · guided discovery of novel biomarkers and therapeutic glycoenzyme inhibitors for cancer
HEIndividual fellowship2027–2029Switzerland